Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dilated Cardiomyopathy - Overview
Dilated Cardiomyopathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Dilated Cardiomyopathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Dilated Cardiomyopathy - Companies Involved in Therapeutics Development
Berlin Cures Holding AG
Celixir Ltd
Heartseed Inc
Martin Pharmaceuticals Inc
MyoKardia Inc
Olagenesis Corp
Pfizer Inc
Renovacor Inc
Shionogi & Co Ltd
Dilated Cardiomyopathy - Drug Profiles
BC-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate BAG3 for Dilated Cardiomyopathy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Heartcel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HS-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PF-06802861 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
redasemtide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SAR-440181 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Dilated Cardiomyopathy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Myocardial Infarction and Dilated Cardiomyopathy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
trimetazidine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YS-1402 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Dilated Cardiomyopathy - Dormant Projects
Dilated Cardiomyopathy - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for Dilated Cardiomyopathy, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Dilated Cardiomyopathy, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Dilated Cardiomyopathy - Pipeline by Berlin Cures Holding AG, H1 2020
Dilated Cardiomyopathy - Pipeline by Celixir Ltd, H1 2020
Dilated Cardiomyopathy - Pipeline by Heartseed Inc, H1 2020
Dilated Cardiomyopathy - Pipeline by Martin Pharmaceuticals Inc, H1 2020
Dilated Cardiomyopathy - Pipeline by MyoKardia Inc, H1 2020
Dilated Cardiomyopathy - Pipeline by Olagenesis Corp, H1 2020
Dilated Cardiomyopathy - Pipeline by Pfizer Inc, H1 2020
Dilated Cardiomyopathy - Pipeline by Renovacor Inc, H1 2020
Dilated Cardiomyopathy - Pipeline by Shionogi & Co Ltd, H1 2020
Dilated Cardiomyopathy - Dormant Projects, H1 2020